Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.
In the last several years, global market of Equine Pharmaceuticals and Supplements developed rapidly, with an average growth rate of 4.52% during 2013 to 2017. In 2017, global revenue of Equine Pharmaceuticals and Supplements is nearly 977 M USD; the actual production is about 13700 K Unit.
The global average price of Equine Pharmaceuticals and Supplements is in the increasing trend, from 71.0 USD/Unit in 2013 to 71.3 USD/Unit in 2017. With the situation of global economy, prices will be in increasing trend in the following five years.
The classification of Equine Pharmaceuticals and Supplements includes Pharmaceuticals and Supplements, and the proportion of Pharmaceuticals in 2017 is about 79%.
According to this study, over the next five years the Equine Pharmaceuticals and Supplements market will register a 2.7% CAGR in terms of revenue, the global market size will reach US$ 1160 million by 2024, from US$ 1020 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Equine Pharmaceuticals and Supplements business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Equine Pharmaceuticals and Supplements market by product type, application, key manufacturers and key regions and countries.
This study considers the Equine Pharmaceuticals and Supplements value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Pharmaceuticals
Supplements
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Thoroughbred Horse
Other Types of Horses
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Boehringer Ingelheim
Merck Animal Health
Zoetis
Bayer Animal Health
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Ouro Fino Saude
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Equine Pharmaceuticals and Supplements consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Equine Pharmaceuticals and Supplements market by identifying its various subsegments.
Focuses on the key global Equine Pharmaceuticals and Supplements manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Equine Pharmaceuticals and Supplements with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Equine Pharmaceuticals and Supplements submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
